EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review

Takehiro Okabayashi, Motoyasu Tabuchi, Teppei Tokumaru, Sunao Uemura, Shuta Tamura

Annals of Pancreatic Cancer · 2026-11 · 9 · 29-29

DOI: 10.21037/apc-26-0030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-11. Verfasst von Takehiro Okabayashi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026). Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review. Annals of Pancreatic Cancer, 9, 29-29. https://doi.org/10.21037/apc-26-0030

Vancouver

Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review. Annals of Pancreatic Cancer. 2026;9:29-29. doi:10.21037/apc-26-0030

BibTeX
@article{Okabayashi2026,
  author = {Okabayashi, Takehiro and Tabuchi, Motoyasu and Tokumaru, Teppei and Uemura, Sunao and Tamura, Shuta},
  title = {Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review},
  journal = {Annals of Pancreatic Cancer},
  year = {2026},
  volume = {9},
  pages = {29--29},
  doi = {10.21037/apc-26-0030}
}
Kostenlos starten →